Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suvankar Pal

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Practical Neurology|March 4, 2021
Visual misperceptionsRyan Keh, Sarah Al-Bachari, Mohanned Mustafa, et al.
Transfusion|June 22, 2010
A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase KM Howard Tattum, Samantha Jones, Suvankar Pal, et al.
Brain Communications|October 23, 2020
Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of <i>in vitro</i> studiesKoy Chong Ng Kee Kwong, Jenna M Gregory, Suvankar Pal, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 21, 2020
National audit of cognitive assessment in people with pwMND A national audit of cognitive assessment in people with motor neurone disease (pwMND) in ScotlandMaria Stavrou, Judith Newton, Gill Stott, et al.
Brain : a Journal of Neurology|May 10, 2022
Smarter adaptive platform clinical trials in neurology: a showcase for UK innovationArpan R Mehta, Suvankar Pal, Jeremy Chataway, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 14, 2019
Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALSJenna M Gregory, Karina McDade, Thomas H Bak, et al.
BMJ Open|March 24, 2021
Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocolEmily Beswick, Stella A Glasmacher, Rachel Dakin, et al.
International Journal of Geriatric Psychiatry|May 13, 2021
Validation of The Edinburgh cognitive and behavioural ALS screen (ECAS) in behavioural variant frontotemporal dementia and Alzheimer's diseaseMónica M De Icaza Valenzuela, Thomas H Bak, Harriet E Thompson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 10, 2019
An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in ScotlandElizabeth Elliott, Judith Newton, Phillipa Rewaj, et al.
Neuro-Degenerative Diseases|April 26, 2021
The Prevalence and Management of Saliva Problems in Motor Neuron Disease: A 4-Year Analysis of the Scottish Motor Neuron Disease RegisterIona Pearson, Stella A Glasmacher, Judith Newton, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Practical Neurology|March 4, 2021
Visual misperceptionsRyan Keh, Sarah Al-Bachari, Mohanned Mustafa, et al.
Transfusion|June 22, 2010
A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase KM Howard Tattum, Samantha Jones, Suvankar Pal, et al.
Brain Communications|October 23, 2020
Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of <i>in vitro</i> studiesKoy Chong Ng Kee Kwong, Jenna M Gregory, Suvankar Pal, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 21, 2020
National audit of cognitive assessment in people with pwMND A national audit of cognitive assessment in people with motor neurone disease (pwMND) in ScotlandMaria Stavrou, Judith Newton, Gill Stott, et al.
Brain : a Journal of Neurology|May 10, 2022
Smarter adaptive platform clinical trials in neurology: a showcase for UK innovationArpan R Mehta, Suvankar Pal, Jeremy Chataway, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 14, 2019
Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALSJenna M Gregory, Karina McDade, Thomas H Bak, et al.
BMJ Open|March 24, 2021
Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocolEmily Beswick, Stella A Glasmacher, Rachel Dakin, et al.
International Journal of Geriatric Psychiatry|May 13, 2021
Validation of The Edinburgh cognitive and behavioural ALS screen (ECAS) in behavioural variant frontotemporal dementia and Alzheimer's diseaseMónica M De Icaza Valenzuela, Thomas H Bak, Harriet E Thompson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 10, 2019
An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in ScotlandElizabeth Elliott, Judith Newton, Phillipa Rewaj, et al.
Neuro-Degenerative Diseases|April 26, 2021
The Prevalence and Management of Saliva Problems in Motor Neuron Disease: A 4-Year Analysis of the Scottish Motor Neuron Disease RegisterIona Pearson, Stella A Glasmacher, Judith Newton, et al.
Pageof 12